BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

760142

215417

INVICTA

img img img img
No Data Available

Invicta Diagnostic Ltd performance

Today’s low

Today’s high

₹ 91.90 ₹ 92.10
₹ 96.70

52 week low

52 week high

₹ 95.00 ₹ 105.00
₹ 96.70

Open Price

₹ 91.90

Prev. Close

₹ 96.70

Volume (Shares)

1363200.00

Total traded value

₹ 1318.21

Upper Circuit

₹ 101.50

Lower Circuit

₹ 91.90

info

Invicta Diagnostic Ltd Share Price Update

As of the latest trading session, Invicta Diagnostic Ltd share price is currently at ₹ 91.9, which is down by ₹ -4.79 from its previous closing. Today, the stock has fluctuated between ₹ 91.90 and ₹ 92.10. Over the past year, Invicta Diagnostic Ltd has achieved a return of [-] %. In the last month alone, the return has been [-] %. Read More...

Invicta Diagnostic Ltd fundamentals


  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    0.0%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    0.0%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

Invicta Diagnostic Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Book Value / Share 19.99
ROE % 32.33
ROCE % 43.55
Total Debt to Total Equity 0.12
EBITDA Margin 31.83
Particulars MAR 2024 (Values in Cr)
Book Value / Share 925.99
ROE % 22.09
ROCE % 19.72
Total Debt to Total Equity 0.15
EBITDA Margin 46.93
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.60
ROE % 44.39
ROCE % 56.85
Total Debt to Total Equity 0.00
EBITDA Margin 48.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 717.10
ROE % 25.45
ROCE % 25.77
Total Debt to Total Equity 0.00
EBITDA Margin 80.29
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.16
Total Assets 21.25
Total Liabilities 21.25
Total Equity 15.83
Share Outstanding 8417920
Price to Book Ratio 0.00
Return on Assets (%) 22.07
Return on Capital (%) 26.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.33
Total Assets 15.83
Total Liabilities 15.83
Total Equity 11.14
Share Outstanding 131530
Price to Book Ratio 0.00
Return on Assets (%) 16.97
Return on Capital (%) 20.67
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.80
Total Assets 17.49
Total Liabilities 17.49
Total Equity 14.81
Share Outstanding 8417920
Price to Book Ratio 0.00
Return on Assets (%) 30.76
Return on Capital (%) 36.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.88
Total Assets 11.05
Total Liabilities 11.05
Total Equity 9.42
Share Outstanding 131530
Price to Book Ratio 0.00
Return on Assets (%) 21.71
Return on Capital (%) 25.45
Particulars MAR 2025 (Values in Cr)
Net Income 6.86
Cash from Operations 7.57
Cash from Investing -5.22
Cash from Financing -0.42
Net change in Cash 0.82
Free Cash Flow 8.12
Particulars MAR 2024 (Values in Cr)
Net Income 2.68
Cash from Operations 5.32
Cash from Investing -10.00
Cash from Financing 7.13
Net change in Cash 1.33
Free Cash Flow 18.08
Particulars MAR 2025 (Values in Cr)
Net Income 6.86
Cash from Operations 5.61
Cash from Investing -4.21
Cash from Financing 0.00
Net change in Cash -0.08
Free Cash Flow 5.82
Particulars MAR 2024 (Values in Cr)
Net Income 2.42
Cash from Operations 5.08
Cash from Investing -9.51
Cash from Financing 5.34
Net change in Cash 0.88
Free Cash Flow 10.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7189.25 61.83 11.37 103370.38 6002.15 / 8099.00
FORTIS MALAR HOSPITALS LIMITED 63.05 26.05 3.43 118.17 55.15 / 98.70
SHREE PACETRONIX LTD. 242.65 40.78 5.20 94.63 61.11 / 283.15
TRANSGENE BIOTEK LTD. 3.08 0.00 2.53 23.34 2.90 / 8.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7189.25 73.74 11.09 103370.38 6002.15 / 8099.00
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 45.00 0.00 -13.07 33.62 28.34 / 57.48
KOVAI MEDICAL CENTER & HOSPITA 5924.70 28.35 5.44 6481.62 4810.20 / 6725.00

Invicta Diagnostic Ltd shareholding pattern

Holding

9.48%
90.51%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Invicta Diagnostic Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
96.70 13.76 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
0.0 PIVOT

First Support

0.0

First Resistance

0.0

Second Support

0.0

Second Resistance

0.0

Third Support

0.0

Third Resistance

0.0

RSI

0.0

ADX

0.0

MACD

0.0

Williams % R

0.0

Commodity Channel Index (CCI)

0.0

Date

[-]

Week

0.0

Same Day

0.0

Month

0.0

1 Year

0.0

3 Year

0.0

Over 1 Month

0.0%

down

Over 1 Year

0.0%

down

Over 3 Months

0.0%

down

Over 3 Years

0.0%

down

Over 6 Months

0.0%

down

Over 5 Years

0.0%

down

Invicta Diagnostic Ltd Corporate Actions

Top Gainers

Invicta Diagnostic Ltd Share Price

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre. Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023. Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued to the Company by the Assistant Registrar of Companies, Central Processing Centre.

Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and
pathology solutions. It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers under the brand name 'PC Diagnostics' through extensive operational network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.

The business and brand 'PC Diagnostics' were conceptualised and founded by Dr. Ketan Jayantilal Jain and Dr. Sanket Vinod Jain, Promoters and Non-Executive directors, who are a first-generation entrepreneur in healthcare and have more than 10 years and 7 years of experience, respectively, in integrated diagnostics business and both are a radiologist. The Promoter and Chief Financial Officer, Rohit Prakash Srivastava, have been involved in our business and operations since 2021 as Management Advisor.

The history dates back to 2021, when the Promoters established the first 'PC Diagnostics' Centre in Thane, Maharashtra having the entire gamut of services including PET CT Scans, CT Scans, MRI Scans, Sonography, X-Ray and Pathology. The test menu includes pathology tests ranging from basic biochemistry and clinical pathology which are performed at their own centres to cytogenetics and high-end molecular diagnostic tests which are outsourced to larger reference laboratories, and radiology tests from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests including computerised tomography (CT) scans, magnetic resonance imaging (MRI) scans and advanced positron emission tomography CT (PET CT).

The Company acquired majority shareholding in 'PCD Diagnostics LLP' for a full-fledged diagnostic centre in Marol, Andheri East, forming it as the subsidiary in 2023. Thereafter, it acquired majority shareholding in 'Primacare Healthcare LLP' for a full-fledged diagnostic centre in Byculla, forming it as subsidiary and further acquired majority shareholding in 'Pratham MRI and CT Scan Centre' for a full-fledged diagnostic centre in Bhayandar, forming it a subsidiary in 2023.

In 2024, the Company acquired a diagnostic centre in Sewri from PCD Medical LLP, acquired a diagnostic centre in Parel from Primacare Diagnostic LLP and acquired a centralised laboratory in Parel from Porteus Path Lab LLP. The Company further formed 'Invicta Medical LLP' as a subsidiary for setting up of diagnostic centre in Kalwa, Thane in 2024.

The Company is planning an Initial Public Offer of 30,08,000 fresh issue Equity Shares.

Parent organization Indian Private
NSE symbol INVICTA
Founded 2023
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of INVICTA DIAGNOSTIC LTD?

Answer Field

INVICTA DIAGNOSTIC LTD share price is for NSE ₹ 91.90 & for BSE ₹ 0.00 as on Dec 09 2025 09:31 AM.

What is the Market Cap of INVICTA DIAGNOSTIC LTD Share?

Answer Field

The market cap of INVICTA DIAGNOSTIC LTD for NSE ₹ 77.36 & for BSE ₹ 0.00 as on Dec 09 2025 09:31 AM.

What is the 52 Week High and Low of INVICTA DIAGNOSTIC LTD?

Answer Field

The 52 Week High and Low of INVICTA DIAGNOSTIC LTD for NSE is ₹ 105.00 and ₹ 91.90 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for INVICTA DIAGNOSTIC LTD?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of INVICTA DIAGNOSTIC LTD Share?

Answer Field

As on Dec 09 2025 09:31 AM the price-to-earnings (PE) ratio for INVICTA DIAGNOSTIC LTD share is 0.0.

What is the PB ratio of INVICTA DIAGNOSTIC LTD Share?

Answer Field

As on Dec 09 2025 09:31 AM, the price-to-book (PB) ratio for INVICTA DIAGNOSTIC LTD share is 0.0.

How to Buy INVICTA DIAGNOSTIC LTD Share?

Answer Field

You can trade in INVICTA DIAGNOSTIC LTD shares with Bajaj Broking by opening a demat account.

How to Buy INVICTA DIAGNOSTIC LTD Share on Bajaj Broking App?

Answer Field

To buy INVICTA DIAGNOSTIC LTD shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “INVICTA DIAGNOSTIC LTD”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59